Related Experiment Video
Updated: Jun 24, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Leveraging external controls in clinical trials: estimands, estimation, assumptions
Bo Liu1, Fan Li1, Rury R Holman2
1Department of Statistical Science, Duke University, Durham, NC, USA.
Augmenting randomized controlled trials with external data improves treatment effect estimation. New methods combine concurrent and external controls without strict assumptions, enhancing causal inference accuracy.
Area of Science:
- Biostatistics
- Clinical Trials
- Epidemiology
Background:
- Randomized controlled trials (RCTs) are often augmented with external controls from observational data to assess intervention effects.
- Traditional methods for treatment effect estimation rely on ambiguous causal estimands and strong assumptions like mean exchangeability.
- Implicit biases in causal inference arise from various sources, complicating accurate treatment effect evaluation.
Purpose of the Study:
- To introduce a transparent framework for defining causal estimands using double-indexed potential outcomes notation.
- To develop a novel statistical method for estimating treatment effects by integrating concurrent and external control data.
- To address limitations of existing methods by removing the need for mean exchangeability assumptions.
Main Methods:
- Developed a double-indexed notation for potential outcomes to clearly define causal estimands and identify sources of bias.
- Derived a consistent and locally efficient estimator for weighted average treatment effect (WATE) estimands.
- Proposed a Frisch-Waugh-Lovell style partial regression method to estimate systematic outcome differences between concurrent and external units.
Main Results:
- Demonstrated the critical role of the concurrent control arm in validating assumptions and enabling unbiased causal estimation.
- The proposed estimator successfully combines concurrent and external data without requiring mean exchangeability.
- Simulations and application to cardiovascular trials showed the proposed methods outperform existing approaches.
Conclusions:
- The novel approach offers a more robust and transparent method for causal inference in clinical trials by integrating diverse data sources.
- This framework enhances the reliability of treatment effect estimation when external data is used to augment RCTs.
- The proposed estimator provides a valuable tool for biostatisticians and clinical researchers seeking accurate causal effect evaluation.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Controls in Experiments
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Blinding
Clinical Trials: Overview